未登录

王

王金恒 (Jinheng Wang)

the affiliated traditional chinese medicine hospital教授邮箱:wangjh89@gzhmu.edu.cn

H指数:15

被引数:1,705

个人简介

王金恒，教授，博士生导师。2016年博士毕业于比利时布鲁塞尔自由大学。近年来，围绕“多发性骨髓瘤耐药新机制和治疗新策略”等方向开展研究，以第一或通讯作者在Blood、Cancer Research、Nature Communications、Advanced Science等国际著名期刊发表SCI论文20余篇，其中8篇影响因子大于10。

教育背景

2016.12
比利时布鲁塞尔自由大学博士研究生

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting the mevalonate pathway sensitizes multiple myeloma cells to bortezomib through induction of mitochondrial metabolic disruption

靶向甲羟戊酸通路通过诱导线粒体代谢紊乱使多发性骨髓瘤细胞对硼替佐米更敏感

Cell Communication and Signaling

IF8.9

2026-07-200

OA

A STING signaling relay from tumor cells to macrophages mediates the improved efficacy of combination chemotherapy in pancreatic cancer

肿瘤细胞到巨噬细胞的STING信号传递介导了联合化疗在胰腺癌中的增强疗效

Journal of Biomedical Science

IF12.1

2026-03-040

OAAI

Molecular basis for targeting Caveolin-1 in multiple myeloma therapy

Expert Opinion on Therapeutic Targets

IF4.4

2026-01-280

PRE

Targeting Caveolin-1 in Multiple Myeloma Cells Enhances Chemotherapy and Natural Killer Cell-Mediated Immunotherapy

多发性骨髓瘤细胞靶向Caveolin-1增强化疗和自然杀伤细胞介导的免疫治疗

ADVANCED SCIENCE

IF14.1

2024-12-040

PRE

Single-cell proteomics delineates murine systemic immune response to blast lung injury

COMMUNICATIONS BIOLOGY

IF5.1

2024-11-031

OAAI

GV-971 prevents severe acute pancreatitis by remodeling the microbiota-metabolic-immune axis

NATURE COMMUNICATIONS

IF15.7

2024-09-270

OAAI

Osteogenically committed hUCMSCs-derived exosomes promote the recovery of critical-sized bone defects with enhanced osteogenic properties

APL BIOENGINEERING

IF4.1

2024-02-060

OA

Hypoxic Bone Marrow Stromal Cells Secrete miR-140-5p and miR-28-3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma

CANCER RESEARCH

IF16.6

2023-09-262

PRE

3WJ RNA Nanoparticles-Aptamer Functionalized Exosomes From M2 Macrophages Target BMSCs to Promote the Healing of Bone Fractures

STEM CELLS TRANSLATIONAL MEDICINE

IF4.9

2023-09-2211

OAAI

Tumour-derived small extracellular vesicles contribute to the tumour progression through reshaping the systemic immune macroenvironment

BRITISH JOURNAL OF CANCER

IF6.8

2023-02-085

OA

Melanoma-derived small extracellular vesicles remodel the systemic onco-immunity via disrupting hematopoietic stem cell proliferation and differentiation

IF10.1

2022-10-0115

PRE

Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2022-01-0330

OAAI

Endocytic pathway inhibition attenuates extracellular vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells

IF13.3

2021-01-0142

OAAI

Loading of metal isotope-containing intercalators for mass cytometry-based high-throughput quantitation of exosome uptake at the single-cell level

IF12.9

2020-10-0120

PREAI

Engineered exosome for NIR-triggered drug delivery and superior synergistic chemo-phototherapy in a glioma model

APPLIED MATERIALS TODAY

IF6.9

2020-09-0132

PREAI

Exploration of the personalized immune checkpoint atlas of plasma cell dyscrasias patients using high-dimensional single-cell analysis

ONCOLOGY REPORTS

IF3.9

2020-04-215

OAAI

High-throughput single-cell analysis of exosome mediated dual drug delivery,in vivofate and synergistic tumor therapy

IF5.1

2020-01-0135

PREAI

Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity

IF10.1

2016-07-01111

PREAI

Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression

JOURNAL OF PATHOLOGY

IF5.2

2016-04-07207

OAAI

Bcl-3, induced by Tax and HTLV-1, inhibits NF-κB activation and promotes autophagy

CELLULAR SIGNALLING

IF3.7

2013-12-0119

PREAI